Apoptosis of immature thymocytes mediated by E2/CD99
E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteri...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 1997-03, Vol.158 (6), p.2543-2550 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2550 |
---|---|
container_issue | 6 |
container_start_page | 2543 |
container_title | The Journal of immunology (1950) |
container_volume | 158 |
creator | Bernard, G Breittmayer, JP de Matteis, M Trampont, P Hofman, P Senik, A Bernard, A |
description | E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur. |
doi_str_mv | 10.4049/jimmunol.158.6.2543 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78852785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78852785</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-733c8b66b67fc03371f8e381ae44e528165c03237a2e4584a178cc67d5dc038f3</originalsourceid><addsrcrecordid>eNqFkE1LwzAYx4Moc04_gQg96ald3pMex5wvMPCi55Cmqetol9q0lH57MzrFm6cH_m_w_AC4RTChkKbLfVnX_cFVCWIy4QlmlJyBOWIMxpxDfg7mEGIcI8HFJbjyfg8h5BDTGZilkEkh2RzQVeOazvnSR66IwqDu-tZG3W6snRk766Pa5qXubB5lY7TBy_Vjml6Di0JX3t6c7gJ8PG3e1y_x9u35db3axoYK2sWCECMzzjMuCgMJEaiQlkikLaWWYYk4CzImQmNLmaQaCWkMFznLgy4LsgD3027Tuq_e-k7VpTe2qvTBut4rISXD4Y1_g4ilmEqJQ5BMQdM671tbqKYta92OCkF1hKp-oIaOVFwdoYbW3Wm-zwKO386JYvAfJn9Xfu6GsrXK17qqQhqpYRj-LH0DQt2ASQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15924882</pqid></control><display><type>article</type><title>Apoptosis of immature thymocytes mediated by E2/CD99</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bernard, G ; Breittmayer, JP ; de Matteis, M ; Trampont, P ; Hofman, P ; Senik, A ; Bernard, A</creator><creatorcontrib>Bernard, G ; Breittmayer, JP ; de Matteis, M ; Trampont, P ; Hofman, P ; Senik, A ; Bernard, A</creatorcontrib><description>E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.158.6.2543</identifier><identifier>PMID: 9058785</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>12E7 Antigen ; Antibodies, Monoclonal - pharmacology ; Antigens, CD - immunology ; Antigens, CD - physiology ; Antigens, Differentiation, T-Lymphocyte ; Apoptosis - immunology ; Caspase 1 ; Caspase 3 ; Caspases ; CD3 Complex ; CD4 Antigens ; CD8 Antigens ; Cell Adhesion Molecules - immunology ; Cell Adhesion Molecules - physiology ; Cell Differentiation - immunology ; Child, Preschool ; Cysteine Endopeptidases - drug effects ; Cysteine Proteinase Inhibitors - pharmacology ; fas Receptor - physiology ; Humans ; Immunophenotyping ; Jurkat Cells ; Lectins, C-Type ; T-Lymphocytes - immunology ; T-Lymphocytes - ultrastructure</subject><ispartof>The Journal of immunology (1950), 1997-03, Vol.158 (6), p.2543-2550</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-733c8b66b67fc03371f8e381ae44e528165c03237a2e4584a178cc67d5dc038f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9058785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bernard, G</creatorcontrib><creatorcontrib>Breittmayer, JP</creatorcontrib><creatorcontrib>de Matteis, M</creatorcontrib><creatorcontrib>Trampont, P</creatorcontrib><creatorcontrib>Hofman, P</creatorcontrib><creatorcontrib>Senik, A</creatorcontrib><creatorcontrib>Bernard, A</creatorcontrib><title>Apoptosis of immature thymocytes mediated by E2/CD99</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur.</description><subject>12E7 Antigen</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antigens, CD - immunology</subject><subject>Antigens, CD - physiology</subject><subject>Antigens, Differentiation, T-Lymphocyte</subject><subject>Apoptosis - immunology</subject><subject>Caspase 1</subject><subject>Caspase 3</subject><subject>Caspases</subject><subject>CD3 Complex</subject><subject>CD4 Antigens</subject><subject>CD8 Antigens</subject><subject>Cell Adhesion Molecules - immunology</subject><subject>Cell Adhesion Molecules - physiology</subject><subject>Cell Differentiation - immunology</subject><subject>Child, Preschool</subject><subject>Cysteine Endopeptidases - drug effects</subject><subject>Cysteine Proteinase Inhibitors - pharmacology</subject><subject>fas Receptor - physiology</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Jurkat Cells</subject><subject>Lectins, C-Type</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - ultrastructure</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LwzAYx4Moc04_gQg96ald3pMex5wvMPCi55Cmqetol9q0lH57MzrFm6cH_m_w_AC4RTChkKbLfVnX_cFVCWIy4QlmlJyBOWIMxpxDfg7mEGIcI8HFJbjyfg8h5BDTGZilkEkh2RzQVeOazvnSR66IwqDu-tZG3W6snRk766Pa5qXubB5lY7TBy_Vjml6Di0JX3t6c7gJ8PG3e1y_x9u35db3axoYK2sWCECMzzjMuCgMJEaiQlkikLaWWYYk4CzImQmNLmaQaCWkMFznLgy4LsgD3027Tuq_e-k7VpTe2qvTBut4rISXD4Y1_g4ilmEqJQ5BMQdM671tbqKYta92OCkF1hKp-oIaOVFwdoYbW3Wm-zwKO386JYvAfJn9Xfu6GsrXK17qqQhqpYRj-LH0DQt2ASQ</recordid><startdate>19970315</startdate><enddate>19970315</enddate><creator>Bernard, G</creator><creator>Breittmayer, JP</creator><creator>de Matteis, M</creator><creator>Trampont, P</creator><creator>Hofman, P</creator><creator>Senik, A</creator><creator>Bernard, A</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19970315</creationdate><title>Apoptosis of immature thymocytes mediated by E2/CD99</title><author>Bernard, G ; Breittmayer, JP ; de Matteis, M ; Trampont, P ; Hofman, P ; Senik, A ; Bernard, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-733c8b66b67fc03371f8e381ae44e528165c03237a2e4584a178cc67d5dc038f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>12E7 Antigen</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antigens, CD - immunology</topic><topic>Antigens, CD - physiology</topic><topic>Antigens, Differentiation, T-Lymphocyte</topic><topic>Apoptosis - immunology</topic><topic>Caspase 1</topic><topic>Caspase 3</topic><topic>Caspases</topic><topic>CD3 Complex</topic><topic>CD4 Antigens</topic><topic>CD8 Antigens</topic><topic>Cell Adhesion Molecules - immunology</topic><topic>Cell Adhesion Molecules - physiology</topic><topic>Cell Differentiation - immunology</topic><topic>Child, Preschool</topic><topic>Cysteine Endopeptidases - drug effects</topic><topic>Cysteine Proteinase Inhibitors - pharmacology</topic><topic>fas Receptor - physiology</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Jurkat Cells</topic><topic>Lectins, C-Type</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - ultrastructure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bernard, G</creatorcontrib><creatorcontrib>Breittmayer, JP</creatorcontrib><creatorcontrib>de Matteis, M</creatorcontrib><creatorcontrib>Trampont, P</creatorcontrib><creatorcontrib>Hofman, P</creatorcontrib><creatorcontrib>Senik, A</creatorcontrib><creatorcontrib>Bernard, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernard, G</au><au>Breittmayer, JP</au><au>de Matteis, M</au><au>Trampont, P</au><au>Hofman, P</au><au>Senik, A</au><au>Bernard, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Apoptosis of immature thymocytes mediated by E2/CD99</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>1997-03-15</date><risdate>1997</risdate><volume>158</volume><issue>6</issue><spage>2543</spage><epage>2550</epage><pages>2543-2550</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears to regulate adhesion properties of T cells as previously reported, in particular, the induction of homotypic adhesion in CD4+ CD8+ thymocytes. Apoptosis induced via E2/CD99 displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at the outer leaflet of the plasma membrane. It is not followed by detectable DNA fragmentation, and its time course is much longer than apoptosis induced via the Fas/CD95 pathway. It requires 18 h for completion. E2/CD99-induced apoptosis does not require any RNA or protein synthesis and still occurs following blockage of the Fas pathway. It is, however, dependent on CPP32 and IL-1beta-converting enzyme-type cysteine proteases, as shown by blockade with their respective specific inhibitors. This effect is restricted to double-positive thymocytes carrying an intermediate density of CD3 and including all CD69+ cells. Thus, E2/CD99 apears to mediate a distinctive apoptotic signal at a critical stage of thymocyte differentiation, i.e., when positive selection is known to occur.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>9058785</pmid><doi>10.4049/jimmunol.158.6.2543</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 1997-03, Vol.158 (6), p.2543-2550 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_78852785 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | 12E7 Antigen Antibodies, Monoclonal - pharmacology Antigens, CD - immunology Antigens, CD - physiology Antigens, Differentiation, T-Lymphocyte Apoptosis - immunology Caspase 1 Caspase 3 Caspases CD3 Complex CD4 Antigens CD8 Antigens Cell Adhesion Molecules - immunology Cell Adhesion Molecules - physiology Cell Differentiation - immunology Child, Preschool Cysteine Endopeptidases - drug effects Cysteine Proteinase Inhibitors - pharmacology fas Receptor - physiology Humans Immunophenotyping Jurkat Cells Lectins, C-Type T-Lymphocytes - immunology T-Lymphocytes - ultrastructure |
title | Apoptosis of immature thymocytes mediated by E2/CD99 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T08%3A06%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Apoptosis%20of%20immature%20thymocytes%20mediated%20by%20E2/CD99&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Bernard,%20G&rft.date=1997-03-15&rft.volume=158&rft.issue=6&rft.spage=2543&rft.epage=2550&rft.pages=2543-2550&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.158.6.2543&rft_dat=%3Cproquest_cross%3E78852785%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15924882&rft_id=info:pmid/9058785&rfr_iscdi=true |